NFKB1 and diabetes mellitus: It has been shown that NF-κB activity is increased while gene expression of IκB is decreased in the heart of diabetic mice (23).Recent studies have shown that an IKKβ inhibitor and multiple antioxidants reduce NF-κB activation, proinflammatory cytokine secretion, and ROS concentrations in various models of diabetes (92–94).